Anti-CD20 antibody as Initial therapy for adult-onset minimal change
disease with nephrotic syndrome：a case series report
- shuangxi li
, - JING XU
12 Oct 2024Submitted to Clinical Case Reports 15 Oct 2024Submission Checks Completed
15 Oct 2024Assigned to Editor
21 Oct 2024Reviewer(s) Assigned
25 Oct 2024Review(s) Completed, Editorial Evaluation Pending
28 Oct 2024Editorial Decision: Revise Minor
01 Nov 20241st Revision Received
